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Key Role for Efflux in the Preservative Susceptibility and Adaptive
Resistance of Burkholderia cepacia Complex Bacteria
Laura Rushton,a Andrea Sass,a* Adam Baldwin,b Christopher G. Dowson,b Denise Donoghue,c Eshwar Mahenthiralingama
Cardiff School of Biosciences, Cardiff University, Cardiff, United Kingdoma; Department of Biological Sciences, Warwick University, Coventry, United Kingdomb; Unilever
Research and Development, Port Sunlight, Bebington, Wirral Merseyside, United Kingdomc
Bacteria from the Burkholderia cepacia complex (Bcc) are encountered as industrial contaminants, and little is known about the
species involved or their mechanisms of preservative resistance. Multilocus sequence typing (MLST) revealed that multiple Bcc
species may cause contamination, with B. lata (n 17) and B. cenocepacia (n 11) dominant within the collection examined.
At the strain level, 11 of the 31 industrial sequence types identified had also been recovered from either natural environments or
clinical infections. Minimal inhibitory (MIC) andminimum bactericidal (MBC) preservative concentrations varied across 83
selected Bcc strains, with industrial strains demonstrating increased tolerance for dimethylol dimethyl hydantoin (DMDMH).
Benzisothiazolinone (BIT), DMDMH,methylisothiazolinone (MIT), a blend of 3:1 methylisothiazolinone-chloromethylisothia-
zolinone (M-CMIT), methyl paraben (MP), and phenoxyethanol (PH), were all effective anti-Bcc preservatives; benzethonium
chloride (BC) and sodium benzoate (SB) were least effective. Since B. latawas the dominant industrial Bcc species, the type
strain, 383T (LMG 22485T), was used to study preservative tolerance. Strain 383 developed stable preservative tolerance for M-
CMIT, MIT, BIT, and BC, which resulted in preservative cross-resistance and altered antibiotic susceptibility, motility, and bio-
film formation. Transcriptomic analysis of the B. lata 383 M-CMIT-adapted strain demonstrated that efflux played a key role in
its M-CMIT tolerance and elevated fluoroquinolone resistance. The role of efflux was corroborated using the inhibitor L-Phe-
Arg--napthylamide, which reduced theMICs of M-CMIT and ciprofloxacin. In summary, intrinsic preservative tolerance and
stable adaptive changes, such as enhanced efflux, play a role in the ability of Bcc bacteria to cause industrial contamination.
The Burkholderia cepacia complex (Bcc) has recently expandedand is currently comprised of at least 17 genetically distinct
species groups (1). Bcc members are ubiquitous in nature and are
routinely isolated from a broad range of environments, including
soil, plant rhizospheres, and freshwater, where they can have a
range of beneficial properties (2). However, as opportunistic
pathogens, Bcc bacteria are capable of causing infection in plants,
animals, and vulnerable individuals and are commonly associated
with respiratory infection in patients with cystic fibrosis (CF) (1,
2). In addition, members of the Bcc have been isolated as contam-
inants in a variety of industrial processes (3, 4).
Biocides are extensively used in clinical, agricultural, indus-
trial, and domiciliary settings to reduce spoilage and the risk of
infection. In industry, biocides are also used as preservative agents
incorporated into raw materials and finished products. An inad-
equate preservative system and/or antimicrobial resistance can
result in microbial spoilage; this may cause economic loss and,
depending on the contaminating organism(s), could potentially
pose a risk to the consumer. Members of the Bcc have been iso-
lated from petroleum products (5), antimicrobial solutions (6),
sterile solutions, preserved pharmaceuticals, and preserved cos-
metics and toiletries (3). A review of FDA product recalls (1998 to
2006) reported B. cepacia as the most frequently isolated Gram-
negative contaminant of sterile and nonsterile pharmaceuticals
(3). Outbreaks of Bcc infection in vulnerable individuals have
resulted from the use of contaminated antimicrobial/preserved
industrial products (7–10). Burkholderia contaminans (11) was
given its systematic species name because of its linkage to a
globally distributed strain associated with multiple incidents of
contamination and opportunistic infection (12). Overall, Bcc
bacteria are now recognized as key risk species in microbial
contamination (4).
Bcc bacteria have high innate antimicrobial resistance to both
antibiotics and biocides. A recent survey of Bcc bacteria demon-
strated that susceptibility to chlorhexidine, cetylpyridinum chlo-
ride, triclosan, benzalkonium chloride, and povidone biocides
varied across the complex, with species-dependent differences in
susceptibility being identified (13). The ability of Bcc bacteria to
form biofilms also gives added protection against antibiotics and
biocides, with efflux demonstrated as a key mechanism of chlo-
rhexidine resistance in sessile Burkholderia cenocepacia cells (14).
Adaptation to biocides and preservatives is a recognized phenom-
enon where resistance increases due to the conditions under
which the bacterium is growing (15, 16). The role of adaptive
resistance in the emergence of antimicrobial-tolerant microor-
ganisms is perhaps underestimated, as it is often controversially
considered to be transient (15).However, studies now indicate the
level of increased resistance and the time for which it persists once
the inducing stimulus is removed are largely dependent on the
dose, time of exposure, and bacterial species (15, 17). Stable adap-
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tive resistance to benzalkonium chloride (18), phenoxyethanol
(17), and isothiazolinone biocides (19, 20) has been promoted in
Pseudomonas spp. via progressive subculture in the presence of
sublethal concentrations. B. cenocepacia has been shown to adapt
to a state of increased antibiotic resistance using multiple mecha-
nisms that are underpinned by stable changes in its global gene
expression profile (21). Thus, a major challenge for the manufac-
turing industry is to ensure that balanced preservation strategies
have a sufficient quantity and spectrum of antimicrobials present
to prevent microbial growth and not lead to adaptive antimicro-
bial resistance.
We carried out a novel investigation of Bcc susceptibility to
common preservatives used in manufacturing. Since little is
known about the distribution of different Bcc species in industrial
contamination, a collection of such isolates was characterized us-
ing multilocus sequence typing (MLST) (22) to determine their
strain diversity and species. Using this information, a genetically
diverse panel of Bcc strains was assembled and used to determine
the influence of Bcc taxonomy and isolation source on preserva-
tive susceptibility. Burkholderia lata (11), the most common spe-
cies identified in our industrial collection, was used as a model
species to study adaptive preservative resistance. Progressive sub-
culture of B. lata in the presence of sublethal preservative concen-
trations was carried out, and transcriptomic analysis was used to
determine themolecular basis for adaptive resistance to a cosmet-
ic-grade blend of methylisothiazolinone and chloromethyliso-
thiazolinone. A novel role for efflux in the resistance of B. lata to
these isothiazoline antimicrobials was identified.
MATERIALS AND METHODS
Bacterial collection. A collection of 60 Bcc isolates from a variety of in-
dustrial processes (see Table S1 in the supplemental material) was assem-
bled and identified to the species and strain levels byMLST (22). Sequence
types and allelic data for the isolates were deposited at the Burkholderia
cepacia complex Multi Locus Sequence Typing website (http://pubmlst
.org/bcc). A panel of 83 Bcc strains used for profiling preservative suscep-
tibility was drawn from the aforementioned industrial collection, the Car-
diff University collection (2), and the Belgium Coordinated Collection of
Microorganisms (BCCM) (http://bccm.belspo.be/about/lmg.php; see
Table S2 in the supplemental material). The collection comprised 15 of
the current species groups, five novel Bcc groups defined by MLST, un-
classified novel Bcc strains, reference strains fromBcc experimental strain
panels (23, 24), type strains, and preservative challenge test organisms
(25) (see Table S2 in the supplemental material). The Bcc panel strain
isolation sources varied, and the panel included clinical (n 41; CLIN),
environmental (n 24; ENV), and industrial (n 18; IND) strains. Ten
non-Bcc species were evaluated as a control group, including multidrug-
resistant reference strains of Acinetobacter baumannii and Enterococcus
faecalis; clinical isolates of Pandoraea pnomenusa, Pandoraea sputorum,
Stenotrophomonas maltophilia, andRalstonia pickettii; and environmental
isolates of Pseudomonas fluorescens, Pseudomonas putida, Ralstonia man-
nitolilytica, and Burkholderia gladioli (see Table S3 in the supplemental
material). For consistent revival, strains were cultured at 30°C on tryptic
soya agar; a defined minimal medium (26) was used for preservative sus-
ceptibility and adaptive-resistance testing, as described below.
MIC and MBC determination. Eight commercially available preser-
vative agents frequently used in industrial processes were examined:
benzisothiazolinone (BIT), benzethonium chloride (BC), dimethylol di-
methyl hydantoin (DMDMH),methylisothiazolinone (MIT), a cosmetic-
grademixture of 3:1methylisothiazolinone-chloromethylisothiazolinone
(M-CMIT), methyl paraben (MP), phenoxyethanol (PH), and sodium
benzoate (SB). Standardized agar dilution MIC, broth dilution MIC, and
broth dilution minimum bactericidal concentration (MBC) assays were
carried out using a modified basal salts medium (BSM) (26; see the sup-
plemental material). The MIC was defined as the lowest concentration of
preservative at which there was no visible growth of the test organism. In
the context of the study, resistance was defined as an organism’s ability to
survive “in-use” concentrations (27) as regulated by the cosmetic direc-
tive or at levels recommended by the manufacturer. The MBC was deter-
mined as the lowest concentration at which growth on the recovery me-
dium ceased (see the supplemental material).
Adaptive preservative resistance. B. lata strain 383 (LMG 22485T), a
genome-sequenced strain (http://www.jgi.doe.gov/), was used to evaluate
adaptive preservative resistance. To select for preservative-adapted deriv-
atives, approximately 1  106 CFU of strain 383 from a fresh overnight
BSM broth culture was inoculated onto the surface of BSM agar contain-
ing preservative at a concentration up to four times lower than the MIC.
The plates were incubated for 24 to 96 h at 30°C. Growth on BSM agar (2
or 3 colonies) with the highest preservative concentration was used to
inoculate the next set of training plates, each with a 1.5-fold-increased
concentration of preservative. If no growth was apparent after 96 h, the
fold increase in the preservative concentration was decreased, and fresh
plates were inoculatedwith growth from the previous training plate. Step-
wise training was stopped when subculture onto an increased concentra-
tion did not result in growth within 168 h. This resulted in the successful
isolation of strains 383-M-CMIT, 383-MIT, 383-BIT, and 383-BC, each
named after the preservative to which they had been exposed. Derivatives
with increased resistance to PH, MP, and DMDMH were not observed.
The stability of the phenotypes was confirmed by 10 culture passages in
the absence of preservative. All derivatives were confirmed asB. lata strain
383 by random amplification of polymorphic DNA (RAPD) analysis (28).
Their preservative MICs in comparison with the parental strain 383 were
determined by a standardized broth microdilution assay (see the supple-
mental material).
Analysis of growth dynamics. The growth dynamics of wild-type B.
lata strain 383 and its derivatives were examined using an adapted broth
dilution assay in a Bioscreen CMicrobiological Growth Analyzer (Labsys-
tems, Finland). Overnight broth starter cultures were standardized by
optical density (OD) at 600 nm, and triplicate 200-l cultures in the
multiwell plates were inoculatedwith1 105CFU/ml (200l). Growth
analysis was performed for 72 h at 30°C; turbidity measurements were
taken at 5-min intervals using a wide-band filter (450 to 580 nm) after
shaking themicroplates for 10 s at an intermediate intensity. Experiments
were repeated with different starting cultures to obtain two biological
replicates. Estimations of the length of the lag phase (in hours) and growth
rate () were determined from the mean growth curves generated. The
growth rate was calculated as follows:   (lnNt  lnN0)/(t  t0),
where Nt is the optical density at time t and N0 is the optical density at
time zero (t0).
Antibiotic susceptibility testing. The antibiotic susceptibility of B.
lata 383 and its derivatives was determined using Etest strips, as described
by the manufacturer (AB Biodisk); two biological replicates were per-
formed for each antibiotic MIC. Eight antibiotics were examined as rep-
resentative of those active against different cellular targets (29): amikacin,
azithromycin, ceftazidime, ciprofloxacin, chloramphenicol, piperacillin,
trimethoprim-sulfamethoxazole, and imipenem. An overall antibiotic
susceptibility profile score for the wild type and derivatives was calculated
by averaging the MICs for the eight antibiotics and was used as a measure
of multidrug resistance as described previously (13). A modified broth
microdilution assay was used to further evaluate the susceptibilities of the
parent strain and derivatives to fluoroquinolone antibiotics. Aqueous so-
lutions of fluoroquinolone antibiotics (10 mg/ml) were added to cation-
adjusted Mueller-Hinton (MH) broth to make concentrations ranging
from 0 to 80g/ml for ciprofloxacin, 0 to 256g/ml for levofloxacin, 0 to
1,024 g/ml for norfloxacin, and 0 to 256 g/ml for sparfloxacin. Over-
night liquid cultures were standardized by optical density, and approxi-
mately 1 105 CFUof each strain was added to the test and controlmedia
in triplicate wells of a 96-well plate. Microplates were incubated with
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shaking (150 rpm) at 30°C for 24 h; the MIC was defined as the concen-
tration of preservative at which there was no visible bacterial growth.
Screening for mutations in the topoisomerase genes. The main
mechanism of fluoroquinolone resistance in Gram-negative bacteria de-
velops by accumulation of mutations in the quinolone resistance-deter-
mining region (QRDR)of the topoisomerase genes (30, 31). TheQRDRof
the gyrA and gyrB genes and an extended region (encompassing the
QRDR) of the parC and parE genes were sequenced in the B. lata 383
parent strain and derivatives using the primers listed in Table S4 in the
supplemental material. The amplification conditions were as follows:
DNAwas denatured at 96°C for 1min, followed by 30 cycles of denaturing
at 96°C for 1 min, annealing at 55°C for 1 min, and extension at 72°C for
1 min, followed by a final extension at 72°C for 10min. The amplification
products were purified, and both strands were sequenced using ABI 3100
and BigDye chemistry (Applied Biosystems). Sequences were analyzed
and aligned using the Staden package (32), BioEdit version 7.0.5.3, and
ClustalW, as described previously (5).
Efflux inhibition assays. The effect of efflux activity on preservative
and antibiotic susceptibility of B. lata strain 383 and derivative 383-M-
CMITwas studied using the broad-spectrumefflux inhibitorMC-207,110
L-Phe-Arg--napthylamide (PAN) (Sigma-Aldrich, United Kingdom)
(33–35). The MIC of PAN was determined by the modified broth mi-
crodilution assay. Appropriate amounts of an aqueous stock solution of
PAN (100 mg/ml) were added to BSM broth to achieve a range of con-
centrations (0 to 2.048 mg/ml). A checkerboard assay (21) was used to
evaluate the effect of PAN on the MIC of a ciprofloxacin and M-CMIT
preservative blend. Concentrations of PAN ranging from 0 to 0.512
mg/ml were evaluated in combination with ciprofloxacin at 0 to 30g/ml
and in combination withM-CMIT at a range of 0 to 0.001498%. TheMIC
was defined as the concentration of ciprofloxacin or preservative (alone
and in combination with PAN) at which there was no visible bacterial
growth.
Biofilm and motility assays. A Burkholderia-specific biofilm assay
(36) was used to determine biofilm biomass production of B. lata strain
383. The swarming motilities of the parental B. lata strain 383 and deriv-
atives were determined as follows. Molecular-grade agarose (Bioline,
United Kingdom) was dissolved in Iso-Sensitest broth (ISO) (Oxoid,
United Kingdom) at 2 g/liter and autoclaved. After cooling, 25 ml of the
soft agar was poured into triple-vented petri dishes and dried under lam-
inar flow for 20min. B. lata strain 383, adapted derivatives, and Burkhold-
eria multivorans ATCC 17616 (a reference Bcc strain with excellent
swarming motility) were cultured in ISO broth at 30°C for 18 h and di-
luted to anODof 1 at 600nm.Approximately 5 105CFUwas inoculated
into the agar at the centers of triplicate soft-agar plates and left to dry for
15 min. The plates were incubated at 30°C, and the diameters of the
swarms were measured at 48 h.
Global gene expression.To determine the gene expression alterations
responsible for the stable adaptive phenotype of strain 383-M-CMIT, a
custom 4,000 by 44,000 microarray for B. lata strain 383, designed by
Oxford Gene Technology (United Kingdom) and manufactured by Agi-
lent Technologies (Santa Clara, CA; design number 025314), was used.
The microarray was composed of 14,132 probes; 14,071 probes were de-
rived from coding genes and intergenic regions in the B. lata strain 383
genome, and 61 probes served as internal controls. Each probe was
printed three times with a randomized distribution. To determine global
gene expression differences, B. lata 383 and its preservative-adapted 383-
M-CMIT derivative were grown in 250-ml conical flasks with 25 ml of
BSM broth using an inoculum of 2  108 CFU for each strain. After
growth with shaking (150 rpm) at 30°C, cells were harvested at the mid-
logarithmic growth phase, and total RNA was extracted using the Ribo-
Pure Bacteria Kit (Ambion). The experiments were repeated with differ-
ent starting cultures to obtain three biological replicates. A reference
microarray design (21) was used, with Cy5-labeled cDNA derived from
the total RNA run against the control channel of Cy3-labeled strain 383
genomic DNA. Washing, scanning, extraction, and analysis of the gene
expression data using Genespring GX v7.3.1 (Agilent) were performed as
described previously (21). Three biological replicates were compared, and
differential gene expression was examined for the 7,749 coding sequences
(CDS) and 6,324 intergenic (IG) regions of the B. lata genome. Genes
significantly altered in expression (P 0.05)were initially identified using
a 1.5-fold expression change cutoff, as described previously (21). Bioin-
formatic analysis of genes and gene cluster data was performed as de-
scribed previously (21) and by using the Burkholderia Genome Database
(http://www.burkholderia.com; 37).
Real-time qPCR validation of microarray and efflux gene expres-
sion.Quantitative PCR (qPCR) (21)was used to validate the expression of
4 genes observed as upregulated on the microarray analysis (see Table S4
in the supplemental material). Semiquantitative real-time (RT) PCR (38)
was used to corroborate the expression of 2 downregulated genes (for
genes and primers, see Table S4 in the supplemental material). Relative
expression levels of the efflux gene Bcep18194_B1004 were evaluated in
the parental B. lata strain 383, derivatives of strain 383, and three inde-
pendent B. lata strains isolated from environmental industrial sources:
strains BCC1294, BCC1296, and BCC1406. qPCR was performed in trip-
licate as described previously (21); the primers are listed in Table S4 in the
supplemental material.
Amplifications were run on an MJ Research PTC-200 thermal cycler
with the option of real-time fluorescence detection (DNA Engine Opti-
con). Cycling conditions were as follows: after an initial 15-min activation
of the modified Taq polymerase at 95°C, 50 cycles of 15 s at 95°C, 30 s at
62°C, and 30 s at 72°C were performed. Data were obtained at 72°C, and
melting-curve analysis was performed at the end of the PCR to test for
specific PCR products. The expression level of phaC (Bcep18194_A5090),
a gene that had stable expression across all microarray conditions, was
used as a reference to correct for differences in the amounts of starting
material. This method was applied to the analysis of two total-RNA ex-
tractions from independent biological replicates cultured in BSM broth,
as described formicroarray experiments. A total of 0.1g of the extracted
RNA was converted to cDNA using an Improm-II Reverse Transcription
System (Promega), and 500 ng of cDNA was added to each PCRmixture.
A negative control and a genomic-DNA contamination control were in-
cluded. The efficiency of the PCRwas determined by serial dilutions of the
cDNA template. Accurate levels of expressionwere calculated using delta-
delta and Pfaffl methods of analysis (39).
Statistical analysis. Significant differences (P  0.05) in the MIC or
MBC values of Bcc strains isolated from clinical, environmental, and en-
vironmental industrial sources were determined using Kruskal-Wallis
andMann-Whitney (two-tailed test) statistical tests. Only statistically sig-
nificant gene expression changes (P  0.05) with 1.5-fold alteration
were identified, as described previously (21).
Microarray data accession number. The microarray experimental
protocols and raw data were submitted to ArrayExpress (http://www.ebi
.ac.uk/arrayexpress/) under the accession number E-MEXP-2827.
RESULTS
Bcc species diversity in industry.MLST analysis of a collection of
60 Bcc isolates recovered from industrial sources revealed the fol-
lowing species diversity: B. lata, n  15; B. cenocepacia, n  11;
Burkholderia vietnamiensis, n  8; novel Bcc group Kc, n  7;
Burkholderia arboris, n 6;Burkholderia stabilis, n 5;B. cepacia,
n 3;B.multivorans, n 2;B. contaminans, n 2; andBurkhold-
eria ambifaria, n 1 (see Table S1 in the supplemental material).
Only industrial isolates of sequence type 333 (ST333) were en-
countered at different geographic locations, with the other multi-
ple isolates of single STs identified as duplicate cultures from sin-
gle incidents. Comparison of the industrial isolates with theMLST
database revealed that ST119 isolates had also been independently
recovered from the natural environment; representatives of ST50,
ST51, ST98, and ST439 had also been cultured from both the
Rushton et al.
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natural environment and clinical infections; and ST3, ST103,
ST241, ST250, ST338, and ST340 isolates had also been recovered
from clinical infections. A selection of 18 of these industrial iso-
lates spanning six Bcc species groups were included in a strain
collection used to evaluate Bcc preservative susceptibility (see Ta-
ble S2 in the supplemental material).
Bcc preservative susceptibility. The MICs and MBCs of pre-
servative agents used in industrial processes were evaluated for a
collection of 83 representative Bcc strains. The mean and range of
MICs (see Table S5 in the supplemental material) and MBCs (see
Table S6 in the supplemental material) demonstrated that suscep-
tibility varied both between and within species of the Bcc. An
example of the distribution of MIC and MBC values for the M-
CMIT preservative blend is shown in Fig. 1. For six of the eight
preservatives evaluated, strains with MIC and/or MBC values
above the maximum level permitted for use in personal-care
products were identified (Table 1). Themaximumpermitted level
of sodium benzoate (0.5%) effectively inhibited the growth of 80
Bcc strains but was not high enough to kill the majority of Bcc
strains (79/83 survived exposure). Benzethonium chloride failed
to inhibit the growth of themajority (77 out of 83) of Bcc strains at
maximum permitted levels of 0.1%; 14 Bcc strains (predomi-
nantly B. cenocepacia) showed a high tolerance for benzethonium
chloride, with MBCs up to 10 times greater than the maximum
permitted level. Isothiazolinone preservatives demonstrated
higher efficacy at permitted levels and were bactericidal to 82 out
of 83 Bcc strains. Maximum permitted levels of DMDMH (0.3%)
and PH (1%) had the greatest anti-Bcc activity, inhibiting and
killing all 83 Bcc strains. DMDMH was the only agent to inhibit
and kill all 93 test organisms at the maximum permitted level.
The relationship between isolation source and Bcc preservative
susceptibility was investigated. DMDMH had significantly higher
(P 0.0001) meanMIC andMBC values for Bcc bacteria isolated
from industrial sources than for Bcc bacteria from clinical or en-
vironmental sources (Fig. 2). Mean MBC values of the remaining
preservatives did not significantly differ in relation toBcc isolation
FIG 1 Susceptibility of Bcc species toM-CMIT. (A)MICs. (B)MBCs. Themaximum level for use in rinse-off personal-care products in EU-regulated countries
is 0.0015% (EU cosmetics directive 76/768/EEC annex VI).
B. cepacia Complex Preservative Susceptibility
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sources. The mean MICs of phenoxyethanol (0.25%) and methyl
paraben (0.1%) for Bcc bacteria isolated from environmental
sources were significantly higher (P  0.05) than MICs for Bcc
bacteria from other sources. Mean MICs of sodium benzoate for
Bcc bacteria from clinical sources (0.23% 	 0.15) were signifi-
cantly higher (P  0.05) than MICs for Bcc bacteria from other
sources.
The preservative susceptibilities of the 83Bcc bacteriawere also
compared with those of a control group of 10 non-Bcc species.
M-CMIT had significantly higher MIC and MBC values for Bcc
bacteria than for the non-Bcc control group. Benzethonium chlo-
ride (0.148% 	 0.07%) and sodium benzoate (0.27% 	 0.09%)
also had significantly higher mean MICs for the group of Bcc
strains than for the non-Bcc species group (mean MICs of
0.049% 	 0.07% and 0.13% 	 0.09%, respectively). Phe-
noxyethanol had a significantly highermeanMBC (1.3%	 1.3%)
and methyl paraben had a significantly higher mean MIC
(0.105% 	 0.114%) for the non-Bcc species group than for the
Bcc species group (0.58%	 0.19% and 0.093%	 0.02%, respec-
tively).
Adaptive preservative resistance in B. lata strain 383. Stable
adaptive resistance to M-CMIT, MIT, BIT, and BC preservatives
was promoted via progressive subculture on agar containing in-
creasing concentrations of the preservative agent. Adaptive resis-
tance to DMDMH, PH, and MP was not observed. The adaptive
resistance remained stable after 10 rounds of progressive subcul-
ture in the absence of preservative. The preservative MICs for
derivatives 383-M-CMIT, 383-BIT, and 383-BC increased up to
4-fold, while the MIC of MIT for the derivative 383-MIT re-
mained at wild-type levels (Table 2). In the absence of preserva-
tive, derivative 383-MIT had a significantly longer generation
time (0.33 	 0.02 h), while that of 383-BC was significantly
shorter (0.20 	 0.01 h) than that of the parental strain (0.23 	
0.02 h). Derivatives 383-MIT, 383M-CMIT, and 383-BC also had
significantly longer lag phases (7.83	 0.44 h, 7.96	 0.33 h, and
10.50 	 0.45 h, respectively) than the wild type (6.25 	 0.27 h).
Growth curve analysis of 383-MIT cultured in the presence of
isothiazolinone preservatives demonstrated that the derivative
was capable of growth in concentrations 2-fold higher than that of
the wild type after an extended lag phase of 35.70	 2.95 h. MIC
tests, read at 24 h, failed to identify the increase in tolerance for
MIT in the B. lata 383-MIT derivative. All adapted derivatives
except 383-MIT had reduced swarming motility (Table 2). Bio-
film biomass formation had significantly increased in derivatives
383-M-CMIT and 383-BC from wild-type levels (Table 2).
The preservative susceptibility profiles of adapted strains var-
ied as follows. M-CMIT- and BIT-induced adaptive resistance in
strain 383 conferred cross-resistance between the related com-
pounds: 38-M-CMIT and 383-BIT each demonstrated 4-fold-in-
creased MICs of M-CMIT and BIT compared to parental-strain
levels. Adaptive resistance to benzethonium chloride did not con-
fer cross-resistance to isothiazolinone preservatives; however, it
TABLE 1 Bcc species with individual preservative MIC and MBC values greater than the maximum regulated concentration used in personal-care
products
Species or MLST group
(no. of strains evaluated)
No. of strains with MICs and MBCs above the regulated preservative concna
MIT M-CMITb BITc BC DMDMH PH SB
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
B. ambifaria (4) 3 2
B. anthina (2) 2 2
B. arboris (4) 4 3
B. cenocepacia (15) 14 9 1 14
B. cepacia (4) 3 1 3
B. contaminans (5) 5 1 5
B. diffusa (3) 1 3 3
B. dolosa (3) 1 3 3
B. lata (5) 4 5
B. metallica (2) 2 2
B. multivorans (8) 8 8
B. pyrrocinia (3) 3 3
B. stabilis (3) 3 2
B. ubonensis (1) 1 1
B. vietnamiensis (5) 1 1 4
BCC Kc (4) 3 2 4
BCC4 (3) 3 3
BCC5 (3) 3 3
BCC6 (3) 3 1 3
BCC8 (1) 1 1 1
unclassified BCC (2) 2 2
non-Bcc (10) 1 1 1 3 1 2 3
Total no. of strains (93)d 0 2 0 2 0 2 77 14 0 0 0 2 3 79
a The maximum level for use in rinse-off personal-care products according to European Union (EU) cosmetics directive 76/768/EEC annex VI.
b A cosmetic-grade commercial blend of methylisothiazolinone and chloromethylisothiazolinone.
c Not permitted for use in personal-care products in EU-regulated countries as of 2011; concentrations were evaluated based on the manufacturer’s recommended level.
d Total, 93 strains: 83 Bcc and 10 non-Bcc.
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increased susceptibility toMP andPH (eachwith a 2-fold decrease
in MIC from parental strain levels). Adapted derivatives of B. lata
383 had altered antibiotic susceptibility profiles for 5 out of 8
antibiotics tested (Table 3). In particular, derivatives 383-M-
CMIT and 383-BIT had increased tolerance for chloramphenicol
and a 25-fold-increased MIC of ciprofloxacin (Table 3); the
MICs of three additional fluoroquinolones, levofloxacin, nor-
floxacin, and sparfloxacin, also increased (data not shown). No
mutationswere found in or surrounding theQRDRgenes in theB.
lata 383 derivatives to explain their increased fluoroquinolone
resistance. The overall antibiotic profile score (Table 3) (13) indi-
cated that all preservative derivatives were less multidrug resistant
than the wild-type strain, despite the latter’s alterations to specific
antibiotics.
Expression analysis of adapted B. lata 383-M-CMIT. Tran-
scriptomics were used to identify differentially regulated genes in
the preservative-adapted strainB. lata 383-M-CMITbecause of its
striking phenotypic alterations (Tables 2 and 3). Of the 7,749 cod-
ing sequences, 126 genes were significantly upregulated (see Table
S7 in the supplementalmaterial) and 90 downregulated (see Table
S8 in the supplemental material) in the 383-M-CMIT derivative.
Microarray performance was robust and reproducible, as had
been observed with other Burkholderia custom arrays using the
same platform (14, 21, 38, 40), with 4 upregulated genes validated
by qPCR (see Table S4 in the supplemental material) and 2 down-
regulated genes validated by semiquantitative RT-PCR (data not
shown). Of the 216 differentially expressed genes, 81, 103, and 32
were located on the first, second, and third chromosomal repli-
cons of B. lata, respectively. The genes were associated with 19
clusters of orthologous groups (COG) categories; 89 were poorly
characterized, 80 were involved in metabolism, 31 were involved
in cellular processes and signaling, and 16 were involved in infor-
mation storage and processing (see Table S7 in the supplemental
material). Of the 90 downregulated genes, the largest change (6.3-
fold) was associated with a gene encoding chorismate mutase
(B0668) (see Table S8 in the supplemental material). This had
73% homology to the salicylate biosynthesis protein PchB in P.
FIG 2 Increased tolerance for dimethyol dimethyl hydantoin in Bcc isolates
from industrial sources. The mean minimum inhibitory concentrations (A)
and mean minimum bactericidal concentrations (B) of Bcc isolates from in-
dustrial sources were significantly higher than the values for Bcc isolates from
clinical and environmental sources (*, P 0.0001; two-tailed Mann-Whitney
test). In EU-regulated countries, a maximum level of 0.3% DMDMH is regu-
lated for use in rinse-off personal-care products (EU cosmetics directive 76/
768/EEC annex VI). The error bars show standard errors.
TABLE 2 Preservative susceptibility profiles, swarming motilities, and biofilm biomass production of B. lata 383 derivatives with adaptive resistance
B. lata strain
Preservative susceptibilitya
Swarming motility
(diam [mm]) (SD)
Biofilm productione
(mean OD at 570 nm) (SD)
Mean MIC
(%)b
Increase in
MIC (fold)c
Highest tolerated
concn (%)d
Increase in
concn (fold)c
Wild type 50.0 (0) 0.192 (0.025)
383-M-CMIT 0.00018725 4 0.0003745 8 27.5 (2.1) 0.163 (0.019)f
383-MIT 0.0012125 0 0.0012125 2 50.5 (0.7) 0.202 (0.02)
383-BIT 0.0025 4 0.0025 2 27.5 (0.7) 0.192 (0.021)
383-BC 0.025 2 0.025 4 26.0 (2.8) 0.446 (0.112)f
a Preservative agent to which the B. lata derivative developed adaptive resistance through stepwise training.
b Broth dilution assay.
c From wild-type levels.
d Highest concentration of preservative at which growth was observed (Bioscreen MBG analyser).
e Biomass production (crystal violet assay).
f Significant difference from wild type (P 0.0001; Mann-Whitney two-tailed test).
TABLE 3 Antibiotic MICs for B. lata strain 383 and derivatives
B. lata strain
Mean MIC (g/ml) valuea
Antibiotic
profile scoreAMK CIP CHL SXT CAZ
383 wtb 192 1.25 160 0.25 12 73.10
383-MIT 128.0 1.5 128.0 0.25 10 53.55
383-M-CMIT 24 32 256 0.315 12 64.86
383-BIT 10.0 32 256 0.25 10 61.65
383-BC 64 1.25 72 0.315 12 29.91
a AMK, amikacin; CIP, ciprofloxacin; CHL, chloramphenicol; SXT,
trimethoprim-sulfamethoxazole; CAZ, ceftazidime. Breakpoints for the BSAC (British
Society for Antimicrobial Chemotherapy) disk diffusion assay (version 9.1; March
2010) available for Pseudomonas spp. were as follows: AMK,16 g/ml; CAZ, 8 g/ml;
CIP, 1 g/ml.
b wt, wild type.
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aeuriginosa PAO1, involved in the biosynthesis of the siderophore
pyochelin (41).
Three classes of predicted efflux pumps (42) also had altered
expression levels in 383-M-CMIT: the ATP-binding cassette
(ABC) superfamily (genes A3512_3517 and B1768), major facili-
tator superfamily (MFS) (genes B1327 and A4968), and resis-
tance-nodulation-division (RND) superfamily (genes B1004 to
B1006; see Table S7 in the supplemental material). The largest
change in expression was associated with the coregulated RND
efflux pump gene cluster, B1004 to B1006, located on the second
replicon (see Table S7 in the supplemental material). All compo-
nents of the tripartite system were significantly upregulated; the
membrane fusion protein (Bcep18194_B1004 gene) was upregu-
lated 25-fold, and the transport efflux protein and outer mem-
brane proteinwere upregulated 9.3- and 10-fold, respectively. Ad-
ditional microarray analysis demonstrated that expression of this
system was not induced by sublethal concentrations of M-CMIT
(0.00001498%) in the wild type (data not shown).
RND efflux pump gene expression and inhibition. qPCRwas
used to determine the expression of the RND efflux membrane
fusion protein gene B1004 in all isothiazolinone preservative-
adapted B. lata 383 derivatives and in three genetically distinct B.
lata strains isolated from industrial sources. In comparison to the
wild type, transcriptionwas significantly higher in derivatives 383-
M-CMIT (116.8 	 62.4) (values indicate fold change) and 383-
BIT (81.0 	 20.2), whereas 383-MIT had only a 1.6-fold (	1.5)
increase from wild-type levels. Three independent B. lata strains
from industrial sources all had higher levels of transcription than
thewild-typeB. lata 383 andderivative 383-MIT (BCC1296, 5.7	
1; BCC1406, 3.3 	 2.4), with the process contaminant BCC1294
having the largest expression change of the efflux-encoding gene
(236.8	 184.4). (The values represent fold change [mean of bio-
logical duplicates] in comparison to the transcription level in the
wild-type B. lata strain 383.) To corroborate a phenotypic role for
efflux in B. lata isothiazolinone resistance, the ability of the efflux
inhibitor PAN (33) to alter preservative susceptibility was exam-
ined. A concentration of 0.512mg/ml PAN reduced theMICs of
M-CMIT for B. lata strain 383 to 0.0007% (3-fold) and for the
adapted derivative 383-M-CMIT to 0.00625% (4-fold). A corre-
sponding reduction in the fluoroquinolone MIC was also ob-
served at this PAN concentration, with the ciprofloxacin MIC
reduced by 2-fold (0.7	 0.3 g/ml) and 6-fold (1.88 g/ml) for
the parental strain and the 383-M-CMIT derivative, respectively.
DISCUSSION
TheGram-negative species “B. cepacia” is becoming recognized as
one of the most problematic bacterial species for causing indus-
trial contamination (4). “B. cepacia” bacteria belong to a taxo-
nomic complex of closely related species, and this complicates
their study in relation to microbial contamination. Our research
has led to a much clearer understanding of which Bcc species are
prevalent in industrial contamination; the preservative agents to
which they are susceptible; and, for the first time, which preserva-
tives may develop adaptive resistance and themolecular pathways
behind this preservative tolerance, where efflux was a key player.
WhichBcc species are associatedwith industrial contamina-
tion? Incidents of Bcc species contamination are often generically
reported as caused by “B. cepacia” (3, 4); they may often be de-
tected in house by manufacturers and not publically reported.
UsingMLST (22), B. lata and B. cenocepaciawere identified as the
two most common industrial contaminant species in our collec-
tion (see Table S1 in the supplementalmaterial). B. lata belongs to
the taxon K subdivision within the Bcc and was defined at the
same time as another species, B. contaminans (11). B. lata causes
less than 3% of all Bcc CF infections reported in the United States
and has not yet been associated with major outbreaks of infection
(1). In contrast, B. cenocepacia is one of the most problematic Bcc
species, causing 31% of CF infections in the United States and
being linked to multiple outbreaks and epidemics in CF and
non-CF patients (1). While B. cenocepacia is known to be more
tolerant of biocides and antibiotics (13), the industrial prevalence
of B. lata and B. cenocepacia could not be explained by their pre-
servative susceptibility profiles. No particular Bcc species specifi-
cally had a high preservative tolerance; however, we did observe
that Bcc bacteria with elevated tolerance for the formaldehyde-
releasing agent DMDMH were more prevalent in industrial set-
tings (Fig. 2). Bcc species potentially possessmultiple pathways for
formaldehyde detoxification (43); however, a preliminary inves-
tigation of whether Bcc bacteria could grow onDMDMHdemon-
strated that they were incapable of using it as a sole carbon source
(data not shown).
Which commonly used preservatives are most effective
against the Bcc? Bcc bacteria are innately resistant to antimicro-
bials (2), but in relation to preservatives, resistance pathways are
poorly characterized. BIT, DMDMH, MIT, M-CMIT, MP, and
PH all possessed excellent activity against Bcc species, and none of
the 83 strains examined survived exposure to levels of these agents
currently in use (Table 1). BC and SB were not effective agents on
their own (Table 1). DMDMH and PHwere the most bactericidal
agents, killing all Bcc strains examined at their maximum concen-
trations in use, however, the remaining six individual preservative
agents did not achieve this 100% efficacy. Preservative formula-
tions vary greatly, depending on what is permissible or effective in
an industry and product. Single preservative agents are not gener-
ally used in industry, and our data support this practice, as Bcc
strains that could escape inhibition or killing by individual preser-
vatives at the maximum regulated levels (with the exception of
DMDMH) were encountered.
Bcc bacteria can adapt to higher levels of preservative toler-
ance. Adaptive resistance may also play a role in the emergence of
resistant organisms. The ability of Bcc bacteria to increase their
antibiotic resistance is well known, with stable gene expression
changes and cross-resistance to other antibiotics seen after selec-
tion for spontaneous resistance (21). We successfully isolated B.
lata 383 derivatives with elevated tolerance for MIT, C-MIT, BIT,
and BCbut could not achieve this forMP, PH, andDMDMH.The
lack of success in promoting DMDMH tolerance failed to corre-
late with our industrial phenotypic screening data (Fig. 2).
Whether the lack of adaptive resistance seen reflects their efficacy
or was due to selection on agar as opposed to broth-based expo-
sures warrants further study. There are conflicting reports of sta-
ble (20) and unstable (19) isothiazolone resistance seen in adapted
P. aeruginosa. Our data clearly demonstrated that isothiazolone-
adapted B. lata derivatives stably maintain their preservative tol-
erance in the absence of these biocides.
As seen with spontaneous antibiotic resistance in B. cenocepa-
cia (21), exposure of B. lata to single preservative agents led to
stable cross-resistance to other preservatives, especially with re-
gard to tolerance within the isothiazoline family. This emphasizes
the importance of formulating preservatives appropriately to
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avoid leaving particular agents at sub-MIC levels, which can pro-
mote tolerance. No overall increase in antibiotic multidrug resis-
tance was seen in the preservative-adapted Bcc derivatives; how-
ever, one of the most striking cross-resistances observed was the
association of an elevated fluoroquinolone MIC with the isothia-
zolone-adapted derivatives 383-BIT and 383-M-CMIT (Table 3).
This was not due to an accumulation of mutations in the topo-
isomerase genes, as noted for fluoroquinolones (30). Elevated
chlorhexidine resistance has been observed in CF outbreak strains
of B. multivorans and B. cenocepacia, which were multidrug resis-
tant (13). Linkages between antibiotic and biocide resistances
have now been observed for several bacterial species (44). White-
head et al. (45) demonstrated that Salmonella enterica mutants
surviving a single exposure to in-use concentrations of Superkill
(a mixture of aldehydes and quaternary ammonium compounds)
andTrigene (a halogenated tertiary amine) acquired both elevated
antibiotic (nalidixic acid, chloramphenicol, tetracycline, and cip-
rofloxacin) and triclosan resistance.
Efflux is a keymechanismof adaptive preservative resistance
inB. lata.Transcriptomic analysis of the isothiazolinone-adapted
B. lata 383-M-CMIT derivative revealed that the factors necessary
for preservative adaptation were generally inherently encoded
traits of B. lata. Multiple transport-associated genes had altered
expression in 383-M-CMIT (see Tables S7 and S8 in the supple-
mental material), with the greatest change from wild-type tran-
scription associated with the RND efflux pump genes B1004 to
B1006. In B. cenocepacia J2315, the orthologous efflux pump, the
RND-9 system (genes BCAM1945 to BCAM1947), is implicated
in ethidium bromide, beta-lactam, aminoglycoside, and fluo-
rquinolone efflux, and gene deletion results in reduced motility
and increased biofilm formation (40). This phenotype from B.
cenocepacia corroborates that of the preservative-adapted B. lata
383-M-CMIT and 383-BIT derivatives. The phylogenetic distri-
bution of this RND efflux pumpwithin the available Bcc genomes
shows that orthologous systems are limited to B. cenocepacia,
Burkholeria dolosa, B. multivorans, and B. lata (40).
Overexpression of the B1004-to-B1006 RND operon in the
adapted B. lata derivative remained stable in the absence of iso-
thiazolones, suggestingmutation in either the local repressor gene
(B1003, a MerR homologue [40]), a global regulatory gene, or the
promoter region had occurred in 383-M-CMIT and 383-BIT. In-
duction of the RND operon did not occur when the 383 wild type
was exposed to sublethal concentrations of M-CMIT, suggesting
that the preservative substrate may not be directly involved in
regulation of the efflux system. However, because the susceptibil-
ity of both derivatives and the wild-type increased in the presence
of an RND efflux inhibitor, the role of efflux in tolerance for M-
CMIT and BIT preservatives was confirmed. All isothiazolinones
are thiol-interactive biocides; however, chloromethylisothia-
zolinone and benzisothiazolinone are thought to have highly sim-
ilar modes of action (46), perhaps inducing the same RND efflux-
mediated adaptive resistance in B. lata. Outer membrane protein
alterations have been associated with the onset of resistance to
M-CMIT in Bcc bacteria (47) and resistance to CMIT,MIT,MIT/
CMIT and BIT in Pseudomonas spp. (19, 20).
Conclusions.Understanding the diversity of contaminating
Bcc species and their mechanisms of preservative resistance
will enable manufacturers to target these organisms more ef-
fectively. We have identified B. lata as a commonly encoun-
tered industrial species and a suitable model organism for the
study of preservative resistance. B. lata can evolve stable adap-
tive resistance to preservatives, conferring cross-resistance to
structurally related and unrelated antimicrobial agents, includ-
ing certain antibiotics. The potential for adaptive resistance
should perhaps be considered in parallel with the ability of
preservative agents to inhibit growth and/or kill spoilage or-
ganisms. Targeting efflux-mediated adaptive resistance with
inhibitors may potentiate preservative activity and help reduce
the emergence of such resistant organisms. Preservative chal-
lenge test organisms should be expanded in light of our find-
ings to include genetically diverse Bcc bacteria and preserva-
tive-tolerant “in-house” strains recovered from preserved
products. Finally, in order to increase the depth of our under-
standing in this poorly reported area, all Bcc bacteria from
formal product recalls should be accurately identified to the
species level, using available molecular assays (22, 48).
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